- Border adjustment tax or BAT is a tax levied on imports into the US
- The charge is expected to create a level playing field for local manufacturers in the US
- Most Indian companies export their products to the US
- Levying BAT could make Indian medicines expensive in the US
- To remain competitive, Indian companies may have to take a hit on their operating margins
- Trump plans to increase local hiring in IT jobs and reduce work permit visas from India
- Mandatory increase in minimum wages will also add to cost pressures
What’s hot, what's not
| Preferred Stocks | Stocks to avoid |
| ONGC | Infosys |
| Petronet LNG | TCS |
| Gail | Tech Mahindra |
| L&T | Mindtree |
| Grasim | Glenmark Pharma |
| Vedanta | Lupin |
| State Bank of India | Aurobindo Pharma |
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)